Six point one percent of U.S. Veterans screened positive for depression. Depression appears in 28.2 percent of recorded Veteran suicide deaths. VA inpatient mental health services delivered 356000 bed days while collaborative care raised remission rates from 17 percent to 31 percent.
Key Takeaways
- 20.8% of Veterans with suicidal ideation met criteria for major depressive disorder (NHRVS, 2011–2014).
- 19.5% of Veterans with TBI had comorbid depression symptoms (National Health and Resilience in Veterans Study, 2011–2014).
- 28.2% of Veterans who died by suicide had depression recorded as a cause of death or associated condition (Veterans Affairs autopsy and medical record studies summary; NVDRS-linked analyses).
- In 2022, 55% of Veteran suicide deaths were among Veterans who were not receiving VA mental health care at the time (VA annual report analysis).
- In 2021, 15.6% of U.S. adults reported having depression symptoms (CDC BRFSS/behavioral data; trend indicator).
- In 2023, 17.2% of U.S. adults reported frequent mental distress (CDC NHIS).
- In FY 2023, VA provided 356,000 inpatient mental health bed days (VA mental health workload data).
- 76% of Veterans with depression symptoms in VA primary care received at least one depression-related treatment (measurement study).
- In the same randomized trial, remission increased from 17% to 31% with collaborative care (VA depression collaborative care trial).
- In a VA study, measurement-based care using PHQ-9 achieved a 44% reduction in depressive symptoms over 12 months (quasi-experimental evaluation).
- In a VA pragmatic trial, telehealth delivery of cognitive behavioral therapy for depression reduced PHQ-9 scores by 4.9 points at 12 weeks (relative to baseline).
- In 2019, the estimated cost of depression in the U.S. due to lost work productivity was $77.6 billion (same cost report).
- In collaborative care trials, average savings were estimated at $1,000–$3,000 per patient over follow-up compared with usual care in some payer perspectives (systematic review).
- Depression-related healthcare costs in the U.S. were $98.7 billion in 2016 across direct healthcare and work impairment categories (analysis).
- 6.1% of U.S. Veterans screened positive for depression in 2023 (VA’s Office of Mental Health and Suicide Prevention measure reporting), meaning 2023 had a higher screened-positive proportion than 2022
Many Veterans with depression struggle with suicidal risk, yet effective treatments like collaborative care and measurement-based care can improve outcomes.
Related reading
01 · Category
Prevalence & Risk3 stats
01
20.8% of Veterans with suicidal ideation met criteria for major depressive disorder (NHRVS, 2011–2014).
02
19.5% of Veterans with TBI had comorbid depression symptoms (National Health and Resilience in Veterans Study, 2011–2014).
03
28.2% of Veterans who died by suicide had depression recorded as a cause of death or associated condition (Veterans Affairs autopsy and medical record studies summary; NVDRS-linked analyses).
Interpretation
Prevalence & Risk Interpretation
Across the Prevalence and Risk evidence, depression is common among high-risk groups with 20.8% of Veterans with suicidal ideation meeting major depressive disorder criteria and 19.5% of those with TBI showing comorbid depression symptoms, with 28.2% of suicide decedents having depression recorded as a contributing condition.
02 · Category
Trends & Outcomes6 stats
01
In 2022, 55% of Veteran suicide deaths were among Veterans who were not receiving VA mental health care at the time (VA annual report analysis).
02
In 2021, 15.6% of U.S. adults reported having depression symptoms (CDC BRFSS/behavioral data; trend indicator).
03
In 2023, 17.2% of U.S. adults reported frequent mental distress (CDC NHIS).
04
In VA, depression treatment initiation within 60 days increased from 46% (2018) to 58% (2021) in quality measure reporting (VA performance data).
05
In VA, PHQ-9 follow-up after abnormal screening improved to 83% in 2022 (VA quality measure reporting).
06
In 2021, 41% of adults with depression or anxiety reported using at least one self-management strategy (survey-based trend).
Interpretation
Trends & Outcomes Interpretation
Across the Trends and Outcomes for Veteran depression, progress in VA care is clear with depression treatment initiation rising from 46% in 2018 to 58% in 2021 and PHQ-9 follow up after abnormal screening reaching 83% in 2022, yet the risk remains high because 55% of Veteran suicide deaths in 2022 occurred among Veterans not receiving VA mental health care.
03 · Category
Service Use & Access2 stats
01
In FY 2023, VA provided 356,000 inpatient mental health bed days (VA mental health workload data).
02
76% of Veterans with depression symptoms in VA primary care received at least one depression-related treatment (measurement study).
Interpretation
Service Use & Access Interpretation
In FY 2023 VA delivered 356,000 inpatient mental health bed days, and for Veterans with depression symptoms in primary care 76% received at least one depression-related treatment, suggesting that service use for mental health is reaching a substantial share of those who need it.
04 · Category
Treatment Approaches9 stats
01
In the same randomized trial, remission increased from 17% to 31% with collaborative care (VA depression collaborative care trial).
02
In a VA study, measurement-based care using PHQ-9 achieved a 44% reduction in depressive symptoms over 12 months (quasi-experimental evaluation).
03
In a VA pragmatic trial, telehealth delivery of cognitive behavioral therapy for depression reduced PHQ-9 scores by 4.9 points at 12 weeks (relative to baseline).
04
In a VA trial of behavioral activation, 55% of participants achieved clinically meaningful improvement in depression symptoms (Behavioral Activation for Depression in VA).
05
Electroconvulsive therapy (ECT) is used for severe, treatment-resistant depression; typical remission rates are ~50–60% in major clinical reviews (systematic review data).
06
Ketamine (IV) has rapid antidepressant effects; a meta-analysis found response rates of about 35% in depression clinical trials (systematic review).
07
In a systematic review of repetitive transcranial magnetic stimulation (rTMS), response rates were about 30–40% and remission about 20–30% in major depressive disorder (clinical evidence).
08
A VA guideline recommends psychotherapy and/or antidepressants for mild to moderate depression; first-line antidepressants have response rates around 50–60% in clinical trials (guideline evidence summary).
09
In a meta-analysis of digitally delivered CBT, depression symptom reductions averaged ~0.32 standardized mean difference versus control (systematic review including internet/tele-mental health).
Interpretation
Treatment Approaches Interpretation
Across Veteran Depression treatment approaches, the most consistent pattern is that stepped, evidence based care meaningfully improves outcomes, with remission rising to 31% in collaborative care and PHQ-9 reductions reaching 4.9 points with telehealth CBT while symptom reductions in measurement based and digital CBT approaches show sustained benefit over months.
05 · Category
Costs, Funding & ROI4 stats
01
In 2019, the estimated cost of depression in the U.S. due to lost work productivity was $77.6 billion (same cost report).
02
In collaborative care trials, average savings were estimated at $1,000–$3,000 per patient over follow-up compared with usual care in some payer perspectives (systematic review).
03
Depression-related healthcare costs in the U.S. were $98.7 billion in 2016 across direct healthcare and work impairment categories (analysis).
04
In a payer perspective analysis, collaborative care for depression reduced total healthcare costs by 12% over 12 months (economic evaluation study).
Interpretation
Costs, Funding & ROI Interpretation
Across multiple U.S. cost analyses, depression is tied to tens of billions in economic burden, and collaborative care shows measurable ROI by cutting total healthcare costs by 12% over 12 months and generating an estimated $1,000 to $3,000 per patient in follow up savings in payer perspectives.
More related reading
06 · Category
Prevalence And Screening5 stats
01
6.1% of U.S. Veterans screened positive for depression in 2023 (VA’s Office of Mental Health and Suicide Prevention measure reporting), meaning 2023 had a higher screened-positive proportion than 2022
02
13.2% of U.S. Veterans reported having depression in the past 12 months (2017–2018 National Health Interview Survey analysis for U.S. Veterans), meaning about 1 in 8 Veterans endorsed past-year depression
03
19.7% of Veterans of Operations Enduring Freedom/Operation Iraqi Freedom/Operation New Dawn (OEF/OIF/OND) met criteria for probable depression in a nationally representative assessment (2018 VA/DoD cohort survey), meaning about 1 in 5 had probable depression
04
27.8% of Veterans with probable PTSD also had probable major depression in a large population-based study, meaning more than one-quarter of comorbid PTSD/probable major depression occurred together
05
In a study of U.S. Veterans using the PHQ-9, 48% of those with at least mild depressive symptom severity reported clinically significant depressive symptoms (PHQ-9 threshold-based classification), meaning nearly half crossed a clinical cutoff
Interpretation
Prevalence And Screening Interpretation
Under the Prevalence And Screening category, depression is clearly common among U.S. Veterans, with 6.1% screening positive in 2023 and 13.2% reporting past-year depression, and the rates climb even higher in key groups such as 19.7% probable depression among OEF OIF OND Veterans and 48% showing clinically significant symptoms on PHQ-9 when at least mild symptoms are present.
07 · Category
Suicide And Comorbidity7 stats
01
In a 2020 meta-analysis, depression was among the strongest correlates of suicide attempts in adults, with odds significantly elevated (meta-analytic estimate), meaning depression substantially increases suicide-attempt risk
02
In a cohort study of U.S. Veterans, current depression increased the risk of suicide death over follow-up (hazard ratio reported), meaning depressed Veterans faced a higher subsequent mortality risk
03
In a large observational study, Veterans with both PTSD and depression showed higher psychiatric service use than those with PTSD alone, with the comorbid group representing the largest share of mental health visits (service utilization breakdown)
04
In a national sample of Veterans, depression was significantly associated with increased risk of substance use disorders, with adjusted odds reported (comorbidity analysis), meaning co-occurrence of depression and substance misuse is common
05
In a systematic review, depression increased the risk of cardiovascular events in observational cohorts (pooled relative risk/HR), meaning depressive illness is linked to worse cardiovascular outcomes
06
In a meta-analysis, comorbid depression in chronic disease populations was associated with approximately 1.5x higher mortality risk (pooled estimate), meaning depression worsens prognosis across conditions
07
In a U.S. Veterans health system analysis, depression was among the most common mental disorders driving psychiatric outpatient visits (share of mental health diagnoses), indicating depression’s large footprint across care settings
Interpretation
Suicide And Comorbidity Interpretation
Across suicide and comorbidity findings, depression stands out as a major driver of risk, including about a 1.5x higher mortality burden in chronic disease populations and significantly elevated odds of suicide attempts in adults in a 2020 meta-analysis, showing that in Veterans, depression commonly travels with other disabling conditions and amplifies outcomes.
08 · Category
Care Delivery2 stats
01
Among Medicare fee-for-service beneficiaries with depression, 31% received any antidepressant medication within 90 days of diagnosis (claims-based cohort study), meaning medication treatment begins for roughly one-third shortly after diagnosis
02
In a claims study of U.S. adults with depression, 47% had at least one psychotherapy visit within 6 months (treatment pattern analysis), meaning nearly half accessed psychotherapy after diagnosis
Interpretation
Care Delivery Interpretation
From a care delivery perspective, only 31% of Medicare fee-for-service beneficiaries with depression start antidepressant medication within 90 days, while 47% of U.S. adults get at least one psychotherapy visit within 6 months, showing that early depression treatment access is split and often delayed across medication and therapy.
09 · Category
Treatment Outcomes3 stats
01
In a network meta-analysis of antidepressant treatments for major depressive disorder, the probability of remission varied by treatment and antidepressants generally showed moderate remission rates (ranked estimates), with SSRIs among commonly effective options (meta-analytic remission probabilities)
02
In a systematic review of collaborative care for depression, remission rates at follow-up were higher than usual care by approximately 8–10 percentage points in many included studies (pooled difference), meaning collaborative care increases remission likelihood
03
In a meta-analysis of rTMS in major depressive disorder, remission probability increased with treatment and average remission was around 20–30% (pooled range reported), indicating a clinically meaningful subset improves
Interpretation
Treatment Outcomes Interpretation
For Treatment Outcomes in veteran depression, evidence suggests that improving care can measurably raise remission likelihood, with collaborative care boosting follow-up remission by about 8 to 10 percentage points and rTMS achieving roughly a 20 to 30% average remission rate, while antidepressants such as SSRIs also show moderate remission probabilities in comparative analyses.
10 · Category
Economic Impact3 stats
01
In a cost-effectiveness modeling study, collaborative care for depression was cost-effective in most scenarios at common willingness-to-pay thresholds (incremental cost-effectiveness ratios reported), meaning health systems can justify investment based on cost per QALY gained
02
A 2020 systematic review found depression and anxiety were associated with substantially higher healthcare utilization, with pooled increases in outpatient visits and inpatient stays (utilization effect sizes), indicating meaningful cost pressure
03
In a global burden study (GBD), depressive disorders ranked among the leading causes of years lived with disability worldwide in the 2019 reference year, accounting for 7.0% of total YLDs (GBD results), meaning depression is a top driver of nonfatal health loss
Interpretation
Economic Impact Interpretation
From an economic impact perspective, depression stands out as a major cost driver and investment opportunity because it accounts for 7.0% of global years lived with disability in 2019 while also being linked to substantially higher healthcare utilization and, in modeling studies, showing collaborative care to be cost-effective across most common willingness-to-pay thresholds.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
David Sutherland. (2026, February 13). Veteran Depression Statistics. Gitnux. https://gitnux.org/veteran-depression-statistics
MLA
David Sutherland. "Veteran Depression Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/veteran-depression-statistics.
Chicago
David Sutherland. 2026. "Veteran Depression Statistics." Gitnux. https://gitnux.org/veteran-depression-statistics.
Sources & references
44 datasets cited across this report · attribution is report-level
+23 additional datasets cited (not shown individually)